Tocilizumab in Patients With Polymyalgia Rheumatica Receiving Glucocorticoid Therapy

JAMA Deputy Editor Mary McDermott, MD, gives editorial insight into a randomized clinical trial comparing the efficacy of tocilizumab vs placebo in patients with glucocorticoid-dependent polymyalgia rheumatica, published in the September 20, 2022, issue of JAMA. For full details, click ja.ma/3f4GiDD and visit jamanetworkvideo.com/ for more content like this.
Topics discussed in this interview:
00:00 Introduction
00:57 Tocilizumab
01:23 SEMAPHORE Randomized Clinical Trial
01:58 Intervention and Results
03:14 Trial Interpretation and Importance
---------------------------------------------------------------------------------
For more from JAMA
• www.jama.com
• / jamajournal
• / jama_current
• / jama. .
Follow the JAMA Network
• www.jamanetwork.com
• www.jamanetworkaudio.com
• / jamanetwork
• / jamanetwork
• / jamanetwork
• / jamanetwork